Melanoma: Double BRAF mutation, double chance to treat?

Dermatol Ther. 2020 Nov;33(6):e13820. doi: 10.1111/dth.13820. Epub 2020 Jul 6.

Authors

Ilaria Proietti¹, Simone Michelini¹, Nevena Skroza¹, Alessandra Mambrin¹, Ersilia Tolino¹, Nicoletta Bernardini¹, Marco Di Fraia¹, Veronica Balduzzi¹, Anna Marchesiello¹, Salvatore Volpe¹, Patrizia Maddalena¹, Antonella Calogero^{2

3}, Giovanna Romeo^{2

3}, Natale Porta^{2

3}, Luca Pacini^{2

3}, Claudio Di Cristofano^{2

3}, Vincenzo Petrozza^{2

3}, Concetta Potenza¹

Affiliations

¹ Department of Medical-Surgical Sciences and Biotechnologies, Dermatology Unit "Daniele Innocenzi", Sapienza University of Rome, Polo Pontino, Italy.
² Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.
³ Pathology Unit, I.C.O.T. Hospital, Latina, Italy.

PMID: 32530551
DOI: 10.1111/dth.13820

No abstract available

Publication types

Letter

MeSH terms

Humans
Melanoma* / genetics
Mutation
Proto-Oncogene Proteins B-raf* / genetics
Skin Neoplasms* / genetics

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf